Status
Ongoing
Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug
Status
Ongoing
Classification
Class I
Report Date
April 24, 2013
Termination Date
—